These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 21083328)
1. A novel LC-MS approach for the detection of metabolites in DMPK studies. Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328 [TBL] [Abstract][Full Text] [Related]
2. Comparison of drug distribution images from whole-body thin tissue sections obtained using desorption electrospray ionization tandem mass spectrometry and autoradiography. Kertesz V; Van Berkel GJ; Vavrek M; Koeplinger KA; Schneider BB; Covey TR Anal Chem; 2008 Jul; 80(13):5168-77. PubMed ID: 18481874 [TBL] [Abstract][Full Text] [Related]
3. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites. Jian W; Edom RW; Xu Y; Gallagher J; Weng N J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016 [TBL] [Abstract][Full Text] [Related]
4. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies. Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites. Ma S; Zhu M Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531 [TBL] [Abstract][Full Text] [Related]
6. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples. Furlong M; Bessire A; Song W; Huntington C; Groeber E Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320 [TBL] [Abstract][Full Text] [Related]
7. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development. Hsieh Y Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291 [TBL] [Abstract][Full Text] [Related]
8. Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS. Liu K; Zhong D; Chen X Bioanalysis; 2009 Jun; 1(3):561-76. PubMed ID: 21083153 [TBL] [Abstract][Full Text] [Related]
9. Identifying and overcoming bioanalytical challenges associated with chlorine-containing dehydrogenation metabolites. Furlong MT; Wujcik CE; Ji C; Su Y Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3092-102. PubMed ID: 20941755 [TBL] [Abstract][Full Text] [Related]
10. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites. Hsieh Y J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187 [TBL] [Abstract][Full Text] [Related]
11. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies. Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS. Xie C; Zhong D; Yu K; Chen X Bioanalysis; 2012 May; 4(8):937-59. PubMed ID: 22533568 [TBL] [Abstract][Full Text] [Related]
13. Chemical derivatization as a tool for optimizing MS response in sensitive LC-MS/MS bioanalysis and its role in pharmacokinetic studies. Niwa M Bioanalysis; 2012 Jan; 4(2):213-20. PubMed ID: 22250803 [TBL] [Abstract][Full Text] [Related]
14. Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater. Bueno MJ; Agüera A; Gómez MJ; Hernando MD; García-Reyes JF; Fernandez-Alba AR Anal Chem; 2007 Dec; 79(24):9372-84. PubMed ID: 18001124 [TBL] [Abstract][Full Text] [Related]
15. Automated liquid microjunction surface sampling-HPLC-MS/MS analysis of drugs and metabolites in whole-body thin tissue sections. Kertesz V; Van Berkel GJ Bioanalysis; 2013 Apr; 5(7):819-26. PubMed ID: 23534426 [TBL] [Abstract][Full Text] [Related]
16. Rapid analysis of isomeric exogenous metabolites by differential mobility spectrometry-mass spectrometry. Parson WB; Schneider BB; Kertesz V; Corr JJ; Covey TR; Van Berkel GJ Rapid Commun Mass Spectrom; 2011 Nov; 25(22):3382-6. PubMed ID: 22002690 [TBL] [Abstract][Full Text] [Related]
17. In vitro formation of phase I and II metabolites of propranolol and determination of their structures using chemical derivatization and liquid chromatography-tandem mass spectrometry. Lampinen Salomonsson M; Bondesson U; Hedeland M J Mass Spectrom; 2009 May; 44(5):742-54. PubMed ID: 19170146 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. Xu RN; Fan L; Rieser MJ; El-Shourbagy TA J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141 [TBL] [Abstract][Full Text] [Related]
19. Minimizing matrix effects while preserving throughput in LC-MS/MS bioanalysis. Ye Z; Tsao H; Gao H; Brummel CL Bioanalysis; 2011 Jul; 3(14):1587-601. PubMed ID: 21756092 [TBL] [Abstract][Full Text] [Related]
20. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction. Nassar AE; Adams PE Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]